768-10-5

Basic information

• Product Name: 2,1,3-BENZOTHIADIAZOL-5-OL
• Synonyms: BENZO[1,2,5]THIADIAZOL-5-OL;2,1,3-BENZOTHIADIAZOL-5-OL;5-Hydroxy-2,1,3-benzothiadiazole;benzo[c][1,2,5]thiadiazol-5-ol
• CAS NO: 768-10-5
• Molecular Formula: C₆H₄N₂OS
• Molecular Weight: 152.17
• Mol File: 768-10-5.mol
• Article Data: 5

Chemical Properties

• Melting Point: 155 °C
• Boiling Point: 291.1±13.0 °C(Predicted)
• Appearance: /
• Density: 1.554±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 7.41±0.40(Predicted)
• CAS DataBase Reference: 2,1,3-BENZOTHIADIAZOL-5-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 2,1,3-BENZOTHIADIAZOL-5-OL(768-10-5)
• EPA Substance Registry System: 2,1,3-BENZOTHIADIAZOL-5-OL(768-10-5)

Safety Data

• Hazardous Substances Data: 768-10-5(Hazardous Substances Data)

Usage

Structure

Five-membered heterocyclic compound containing one sulfur (S), two nitrogen (N), and two carbon (C) atoms.

Electron-accepting properties

BTO is known for its ability to accept electrons, making it a suitable material for use in organic electronic devices.

Applications

BTO is commonly used as an acceptor material in organic solar cells and organic light-emitting diodes (OLEDs).

High electron affinity

BTO has a high electron affinity, which allows it to form stable radical anions.

Suitability for organic electronics

Due to its high electron affinity and ability to form stable radical anions, BTO is suitable for use in various organic electronic applications.

Potential as a fluorescence probe

BTO has potential for use as a fluorescence probe, which could be beneficial in biological imaging and sensing applications.

Upstream product

• 1753-21-5 5-Ethoxy-2,1,3-benzothiadiazole 
• 1753-76-0 5-Methoxy-2,1,3-benzothiadiazol 
• 1197-37-1 4-ethoxy-benzene-1,2-diamine 
• 102-51-2 4-methoxy-1,2-phenylenediamine 
• 2207-32-1 5-chloro-2,1,3-benzothiadiazole 
• 99-56-9 4-Nitrophenylene-1,2-diamine 
• 16252-88-3 5-nitro-2,1,3-benzothiadiazole 
• 874-37-3 benzo[1,2,5]thiadiazol-5-ylamine 
• 5448-43-1 6-chloroquinoxaline 
• 95-83-0 4-Chloro-1,2-phenylenediamine 
• 1753-75-9 5-bromobenzo[c][1,2,5]thiadiazole 
• 1168135-03-2 5-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzo[c][1,2,5]thiodiazole 

Downstream Products

• 1753-76-0 5-Methoxy-2,1,3-benzothiadiazol 
• 91330-58-4 4-phenylazo-benzo[1,2,5]thiadiazol-5-ol 
• 1753-21-5 5-Ethoxy-2,1,3-benzothiadiazole 
• 29123-11-3 Benz-2,1,3-thiodiazol-5-hydroxy-essigsaeure 
• 32863-29-9 4-Nitro-5-hydroxybenz-2,1,3-thiadiazol 
• 874-37-3 benzo[1,2,5]thiadiazol-5-ylamine 
• 615-72-5 3,4-diaminophenol 
• 3177-69-3 4-Amino-5-hydroxy-2.1.3-benzothiadiazol 
• 847054-44-8 5-(4-nitro-phenoxy)-benzo[1,2,5]thiadiazol 

Relevant articles and documents

A Monophosphine Ligand Derived from Anthracene Photodimer: Synthetic Applications for Palladium-Catalyzed Coupling Reactions

Herein, we present an air-stable dianthracenyl monophosphine ligand (diAnthPhos) which can be prepared in two steps from commercially available anthracene derivatives. The ligand exhibits excellent efficiency for palladium-catalyzed coupling reactions. In particular, Miyaura borylation of heterocycle-containing electrophiles can be facilitated employing the diAnthPhos ligand with a broad substrate scope and low catalyst loading. The valuable synthetic utility of the new ligand is further demonstrated by a one-pot Miyaura borylation/Suzuki coupling protocol for heteroaryl-containing substrates.

Benzothiadiazole compound and preparation method and use thereof

The present invention relates to a benzothiadiazole compound represented by the following formula I, and a preparation method and use thereof, the benzothiadiazole compound has the biological activityof inhibiting protein-tyrosine-phosphatase SHP2, can be used as a tool compound to study the biological functional relevance of the protein-tyrosine-phosphatase SHP2 in a cell signal transduction process, and provides a new means for prevention and treatment of cancer and metabolic and immune diseases.

Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes

Compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructive pulmonary disease, of Formula (1.0.0): 1 wherein R5 and R6 are